Cargando…
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Sclerostin is a product of mature osteocytes embedded in mineralised bone and is a negative regulator of bone mass and osteoblast differentiation. While evidence suggests that sclerostin has an anti-anabolic role, the possibility also exists that sclerostin has catabolic activity. To test this we tr...
Autores principales: | Wijenayaka, Asiri R., Kogawa, Masakazu, Lim, Hui Peng, Bonewald, Lynda F., Findlay, David M., Atkins, Gerald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186800/ https://www.ncbi.nlm.nih.gov/pubmed/21991382 http://dx.doi.org/10.1371/journal.pone.0025900 |
Ejemplares similares
-
Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
por: Xiong, Jinhu, et al.
Publicado: (2015) -
Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
por: Pacicca, Donna M., et al.
Publicado: (2019) -
A Fluorometric Method for the Quantification of Cell Number in Complex Differentiating Osteoblast-Osteocyte Cultures
por: Yang, Dongqing, et al.
Publicado: (2018) -
Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes
por: Yang, Dongqing, et al.
Publicado: (2018) -
The Amazing Osteocyte
por: Bonewald, Lynda F
Publicado: (2011)